AAM
DGX icon

Azzad Asset Management’s Quest Diagnostics DGX Stock Holding History

Azzad Asset Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$840K Buy
4,286
+14
+0.3% +$2.72K 0.08% 245
2025
Q4 		$741K Sell
4,272
-6
-0.1% -$1.09K 0.07% 273
2025
Q3 		$815K Buy
4,278
+274
+7% +$48.6K 0.08% 259
2025
Q2 		$719K Buy
4,004
+82
+2% +$14.2K 0.08% 252
2025
Q1 		$664K Buy
3,922
+66
+2% +$10.8K 0.08% 252
2024
Q4 		$582K Buy
3,856
+65
+2% +$10.1K 0.11% 145
2024
Q3 		$589K Buy
3,791
+111
+3% +$16.6K 0.07% 264
2024
Q2 		$504K Buy
3,680
+141
+4% +$19.3K 0.06% 264
2024
Q1 		$471K Buy
3,539
+46
+1% +$5.97K 0.05% 273
2023
Q4 		$482K Buy
3,493
+95
+3% +$12.5K 0.06% 268
2023
Q3 		$414K Buy
3,398
+184
+6% +$24.5K 0.06% 273
2023
Q2 		$452K Buy
3,214
+33
+1% +$4.55K 0.06% 283
2023
Q1 		$450K Buy
3,181
+17
+0.5% +$2.43K 0.06% 274
2022
Q4 		$495K Sell
3,164
-4,666
-60% -$671K 0.08% 268
2022
Q3 		$920K Buy
7,830
+23
+0.3% +$3.03K 0.09% 288
2022
Q2 		$949K Buy
7,807
+4,754
+156% +$648K 0.09% 282
2022
Q1 		$418K Sell
3,053
-272
-8% -$37.9K 0.06% 281
2021
Q4 		$575K Sell
3,325
-581
-15% -$88.4K 0.08% 283
2021
Q3 		$568K Buy
3,906
+36
+0.9% +$5.27K 0.08% 282
2021
Q2 		$511K Buy
3,870
+49
+1% +$6.42K 0.08% 283
2021
Q1 		$490K Buy
3,821
+148
+4% +$18.2K 0.08% 276
2020
Q4 		$438K Buy
3,673
+95
+3% +$11.6K 0.08% 258
2020
Q3 		$410K Sell
3,578
-1,120
-24% -$132K 0.08% 257
2020
Q2 		$535K Buy
4,698
+1
+0% +$106 0.13% 231
2020
Q1 		$377K Sell
4,697
-4,635
-50% -$480K 0.11% 253
2019
Q4 		$1.03M Sell
9,332
-953
-9% -$99.4K 0.12% 239
2019
Q3 		$1.13M Buy
10,285
+4,702
+84% +$483K 0.14% 224
2019
Q2 		$568K Buy
5,583
+651
+13% +$62.6K 0.16% 215
2019
Q1 		$443K Buy
+4,932
New +$427K 0.13% 235

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Azzad Asset Management's DGX Position: Q1 2026 in Review

Azzad Asset Management increased its Quest Diagnostics (DGX) stake by 0.33% in Q1 2026, buying an estimated $2.72K and bringing the position to 4,286 shares worth $840K. The position accounts for 0.08% of the portfolio, ranked #245.

Azzad Asset Management first reported a position in DGX in Q1 2019 and has held it in 29 quarters since. The position peaked at $1.13M in Q3 2019. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Azzad Asset Management held 4,286 shares of Quest Diagnostics worth $840K as of Q1 2026.
  • Azzad Asset Management bought 14 Quest Diagnostics shares in Q1 2026, an estimated $2.72K.
  • Quest Diagnostics made up 0.08% of Azzad Asset Management's portfolio in Q1 2026, its #245 holding.
  • Azzad Asset Management first reported a position in Quest Diagnostics in Q1 2019 and has held it in 29 quarters since.
  • Azzad Asset Management's Quest Diagnostics position peaked at $1.13M in Q3 2019.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Azzad Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.